本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Y-mAbs Therapeutics, Inc.

8.58
+0.01000.12%
盤後8.580.00000.00%16:24 EDT
成交量:45.45萬
成交額:389.88萬
市值:3.90億
市盈率:-17.34
高:8.59
開:8.56
低:8.56
收:8.57
52周最高:16.11
52周最低:3.55
股本:4,543.84萬
流通股本:1,859.14萬
量比:0.44
換手率:2.44%
股息:- -
股息率:- -
每股收益(TTM):-0.4948
每股收益(LYR):-0.6692
淨資產收益率:-24.31%
總資產收益率:-8.67%
市淨率:4.46
市盈率(LYR):-12.82

資料載入中...

2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/14

重要事件披露

Form 8-K - Current report
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]